Lead Product(s) : Phentermine,Topiramate
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase IV
Sponsor : Mayo Clinic
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : QSIVA is a combination of phentermine, a sympathomimetic amine anorectic and topiramate extended-release, an antiepileptic drug. It is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adul...
Product Name : Qsymia
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 17, 2023
Lead Product(s) : Phentermine,Topiramate
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase IV
Sponsor : Mayo Clinic
Deal Size : Inapplicable
Deal Type : Inapplicable